| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3873948 | The Journal of Urology | 2010 | 5 Pages |
Abstract
This is the first prospective study to our knowledge to demonstrate that p2PSA provides improved discrimination between prostate cancer and benign disease in screened men with a prostate specific antigen of 2.5 to 10 ng/ml and a negative digital rectal examination.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
![[-2]Proenzyme Prostate Specific Antigen is More Accurate Than Total and Free Prostate Specific Antigen in Differentiating Prostate Cancer From Benign Disease in a Prospective Prostate Cancer Screening Study](/preview/png/3873948.png "First Page Preview: [-2]Proenzyme Prostate Specific Antigen is More Accurate Than Total and Free Prostate Specific Antigen in Differentiating Prostate Cancer From Benign Disease in a Prospective Prostate Cancer Screening Study")
Authors
Brian V. Le, Christopher R. Griffin, Stacy Loeb, Gustavo F. Carvalhal, Donghui Kan, Nikola A. Baumann, William J. Catalona,